Exposure to chronic hypoxia during gestation predisposes infants to neonatal pulmonary hypertension, but the underlying mechanisms remain unclear. Here we test the hypothesis that moderate continuous hypoxia during gestation causes changes in the rho-kinase pathway that persist in the newborn period, altering vessel tone and responsiveness. Lambs kept at 3801 meters above sea level during gestation and the first two weeks of life were compared to those with gestation at low altitude. In vitro studies of isolated pulmonary arterial rings found a more forceful contraction in response to KCl and serotonin (5-HT) in high altitude compared to low altitude lambs. There was no difference between the effects of blockers of various pathways of extracellular Ca 2+ entry in low and high altitude arteries. In contrast, inhibition of rho-kinase resulted in significantly greater attenuation of 5-HT constriction in high altitude compared to low altitude arteries. High altitude lambs had higher baseline pulmonary artery pressures and greater elevations in pulmonary artery pressure during 15 minutes of acute hypoxia compared to low altitude lambs. Despite evidence for an increased role for rho-kinase in high altitude arteries, in vivo studies found no significant difference between the effects of rho-kinase inhibition on hypoxic pulmonary vasoconstriction in intact high altitude and low altitude lambs. We conclude that chronic hypoxia in utero results in increased vasopressor response to both acute hypoxia and serotonin, but that rho-kinase is involved only in the increased response to serotonin.
Introduction
Persistent pulmonary hypertension of the newborn occurs in 1 to 7 out of 1000 live births, and is associated with a mortality rate of 10 to 20% (65). Although the cause of this disease is poorly understood, one risk factor appears to be chronic hypoxia in utero, as infants born at high altitude have as much as 100-fold increased risk of pulmonary hypertension (43) (44) (45) .
Vascular smooth muscle contraction is known to be proportional to the cytosolic Ca 2+ concentration. This is dependent on the entry of extracellular calcium through various voltage-dependent and voltage-independent Ca 2+ pathways, which are critical to initiating the cascade of events that lead to myosin light chain phosphorylation and contraction. The force of contraction achieved at a given cytosolic Ca 2+ concentration is also proportional to the activity of two different rho-kinase isoforms (rhokinase I and II), which maintain phosphorylation of myosin light chain by inhibition of myosin light chain phosphatase (61) . Through rho-kinase contractile tone can be modulated independent of changes in cytosolic Ca 2+ concentrations, which leads to the idea that there is strong coordination between the elevation in Ca 2+ and the overall sensitivity to cytosolic Ca 2+ . These pathways are often simultaneously activated, whether this is due to activation by G-protein receptors, such as serotonin (12, 31, 49) , or by acute alveolar hypoxia that causes hypoxic pulmonary vasoconstriction (26, 53, 55 ). give birth naturally, and were transported to Loma Linda University Animal Care when the lambs were 7 to 10 days of age. After arrival and until study about 7 days later, the high altitude group was kept in a chamber supplied with 14 to 16% oxygen. Both groups of lambs were studied between 10 and 20 days of life.
Methods

Chronic hypoxia-
Pharmacological Considerations-All in vitro studies were performed by measuring dose-response curves for 5-HT in the presence of various blockers of rho-kinase and pathways of extracellular Ca 2+ entry. 5-HT was chosen as it is known to increase both cytosolic Ca 2+ concentrations and rho-kinase activity. The effects of 5-HT on contraction via increases in cytosolic Ca 2+ and activation of Ca2+ sensitization pathways, including rho-kinase, occur primarily via activation of G-protein coupled receptor pathways in pulmonary arteries of fetal and adult sheep (12, 49) , however it's modulation of rho-kinase activity may also occur by uptake of 5-HT into the cell via 5-HT transporters, followed by covalent binding to and activation of rhoA which leads to increased rho-kinase activity (15) . Fasudil and Y27632
were selected for rho-kinase inhibition since these two drugs have been used widely at 10 μM (26, 32), (57, 68) . Nifedipine is commonly used to block L-type Ca 2+ channels (Ca L ) at a concentration of 10 μM, which is at least 2 orders of magnitude above its inhibitory EC 50 for Ca L (12, 30, 49 TRP channels, including TRPC1, TRPC3, TRPC4, TRPC5, TRPC6, and TRPC7 (4, 40, 52). Because SKF 96365 blocks numerous channels these findings were compared with experiments performed using flufenamic acid, which has an unrelated structure and also inhibits a number of TRP channels. Flufenamic acid is commonly used at 100 μM, a concentration that blocks TRPC3, TRPC5, TRPC7 and TRPM2, TRPM4, TRPM5, but may activate TRPC6 (4, 12, 49, 52).
Experiments also were performed to test for an interaction between rho-kinase and reverse-mode sodium-calcium exchange (NCX). The rationale for these studies is that activation of G-protein coupled receptors depolarizes the plasma membrane, which can accentuate Na + influx through a number of TRP channels. Na + entry and membrane depolarization reduce the electrochemical gradient for Na + movement across the plasma membrane, and can reverse Na + /Ca 2+ exchanger transport activity. This switch of the NCX into "reverse mode" augments the increase in intracellular Ca 2+ concentrations when the myocytes are stimulated and potentiates arterial contraction (12, 27, 49, 51, 74, 75) .
To examine the role of Ca 2+ entry through reverse-mode Na + /Ca 2+ exchange, experiments were performed in the presence of SN-6. This inhibitor was used at 30 μM as this is well above the EC 50 for its inhibition of NCX1, NCX2 and NCX3 isoforms (25, 46, 47) . SN-6 blocks NCX1, NCX2, and NCX3 at 30 μM without any known effect on TRPC channels or ryanodine receptors (3), and therefore SN-6 can be used to discriminate NCX related and unrelated effects on vascular contraction (47) . Of note, the pharmacologic profile of these compounds is still not defined completely, and it is possible that there may be overlap, non-specific effects or unknown targets that could cause erroneous findings.
The intravenous dose of fasudil used in the in vivo studies (2.5 mg·kg -1
) was based on studies in rats (2), pigs (60), dogs (58) , and humans (28, 59) . Given the nearly 20-hour combined elimination half-life of fasudil and its active metabolite hydroxyfasudil, and its volume of distribution, we estimate the plasma concentration was greater than 10 μM throughout the experiment. and were kept at 37ºC. The bath fluid was aerated with 95% O 2 -5% CO 2 . Rings were suspended between tungsten wires to measure isometric force and responses were recorded and stored for later analysis, as described in detail (11, 49) . At the beginning of each experiment, the vessel rings were equilibrated thermally without tension for >30 min and then progressively stretched. There was no difference between baseline tensions developed in 304 arteries from 11 low altitude lambs (437 ± 70 dynes) and 244 arteries from 12 low altitude lambs (418 ± 75 dynes) and these values were similar to our previous studies (12, 48, 49, 72) . Tensions were compared to maximum responses obtained by exposure to 125 mM KCl (%T Kmax ). For evaluating dose-response characteristics, arteries were stimulated by cumulatively applying 10 -9 to 10 -4 M 5-HT in log increments without washing between step increases of 5-HT concentration.
Contractility Studies-
The wet weights of the arteries were determined by pooling the weights for the various segments used for each study. Measurements of the lumen diameter were based on arterial width with observations taken using a stage micrometer and stereo microscope (Nikon SMZ-1, Melville, NY). The internal lumen diameter was 707 ± 137 μm in 225 vessels from 11 low altitude and 629 ± 131 μm in 195 vessels from 12 high altitude newborns (p>0.05).
Surgical Instrumentation-Anesthesia was induced with thiopental (10 mg/kg iv) and maintained with 2%
isoflurane after intubation and mechanical ventilation. Catheters were inserted into the brachial artery for measurement of blood pressure, in the right femoral vein for administration of medications, and the right femoral artery for blood gas sampling. A Swan-Ganz catheter was passed from the left femoral vein to the pulmonary artery to measure pulmonary arterial blood pressure. Following thoracotomy a transonic flow probe (Transonics, Inc., Ithaca, NY) was placed around the pulmonary artery and a second probe placed around the left femoral artery to measure pulmonary and hind limb blood flows.
Following surgery, lambs were transitioned to intravenous ketamine at 0. ADInstruments). Heart rate was calculated from the arterial blood pressure waveform.
Arterial blood gases (0.4 ml each) (ABL-5, Radiometer, Copenhagen Denmark) and hemoglobin concentration and oxyhemoglobin saturation (OSM3, Radiometer) were measured at baseline, prior to each hypoxic episode, five minutes after initiating hypoxia, and just prior to the end of each hypoxic episode. Pulmonary capillary wedge pressure was measured at each blood sampling time point by inflation of the Swan-Ganz catheter balloon for three to four breaths.
Data Analysis-Dose-response curves were fitted in Prism 5.0 using a Hill equation (12, 49, 72) .
Computations of pressures, flows, and heart rate were made in five-minute averages following completion of the experiment. Significance of changes with time was measured by one-way ANOVA with repeated measures. Significant differences between the low and high altitude groups were detected using two-way ANOVA with repeated measures. Significance relationships found with ANOVA were followed by Bonferroni's or Newman Keul's multiple comparison post-hoc analyses to detect significant differences at specific time points (Graphpad Prism, v5.0 for Macintosh). For all analysis, statistical significance was assumed for p<0.05.
Results
Vessel ring contractility studies- Figure 1 shows the maximal contractile response of isolated pulmonary artery rings to high concentrations of KCl (125mM) and 5-HT (10μM). Both KCl and 5-HT stimulated a greater contractile response in the high altitude arteries than in controls. High altitude hypoxia increased the KCl-induced tension by approximately 30% when mean responses of low altitude lambs (714 ± 76 dynes; 304 vessels from 11 lambs) were compared to high altitude lambs (927 ± 57 dynes; 244 vessels from 12 lambs) (P<0.05, unpaired students t-test). The contraction due to 10 μM 5-HT also was increased by roughly 30% in high altitude lambs (1787 ± 84 dynes; 46 vessels from 8 lambs), as compared to low altitude lambs (1385 ± 120 dynes; 86 vessels from 11 lambs) (P<0.05, unpaired Student's t-test).
Although the force of contraction was greater in high altitude vessels, chronic hypoxia did not alter the log EC 50 (-6.5 ± 0.1 M vs -6.4 ± 0.1 M) or E max (226 ± 9 vs 233 ± 12 % T kmax ) values for 5-HT contraction.
The stimulation of arteries with 5-HT results in contraction by both increases in intracellular Ca
2+
as well as activation of rho-kinase. To assess the contribution of rho-kinase to the 5-HT-elicited contraction, cumulative dose response curves were performed in the presence and absence of 10 μM fasudil or 10 μM Y27632, two commonly used rho-kinase inhibitors (23, 38, 50, 57, 68, 70). As shown in Figure 2 , arterial tension in control arteries was not significantly reduced by the presence of fasudil (18 vessels in six lambs). In contrast, in high altitude arteries, fasudil reduced the E max from 233% to 164% of T Kmax (p<0.01, 14 vessels from 5 lambs), and Y27632 reduced E max to 144% of T Kmax (p<0.01, 13 vessels from 4 lambs).
A primary mechanism by which rho-kinase increases contraction is by enhancing the sensitivity of the contractile second messenger systems to increased cytosolic Ca 2+ . Previous studies have shown that extracellular Ca 2+ entry is critical to the Ca 2+ -dependent contraction caused by stimulation with 5-HT (12, 14, 49, 56, 72) . There are several pathways for the influx of extracellular Ca 2+ into the cytosol, including L-type Ca 2+ channels, non-selective cation channels (NSCC), and reverse-mode sodium/calcium exchangers (NCX). We therefore decided to test the possible synergy between the roles of rho-kinase and these routes of extracellular Ca 2+ entry by measuring contractile responses to 5-HT in the presence of selective antagonists of these pathways with and without rho-kinase inhibition. We first examined the role of L-type Ca 2+ channels in 5-HT-elicited contraction. As shown in Figure 3 (A and B) , the E max was significantly attenuated by nifedipine to a similar extent in both high altitude (15 arteries from 5 lambs) and control (18 arteries from 6 lambs) arteries. The combination of nifedipine and fasudil attenuated the E max to a greater extent than nifedipine alone, independent of altitude. Neither nifedipine alone, nor the combination of nifedipine and fasudil had a significant effect on the EC 50 .
Recent evidence indicates that 5-HT stimulation activates one or more NSCCs, which contributes to increases in intracellular Ca 2+ concentrations (12, 14, 49, 56) , and elicits contraction in fetal and adult sheep pulmonary arteries (12) . We therefore conducted dose-response curves in the presence of a We next evaluated the role of reverse-mode NCX in 5-HT-elicited contraction by performing experiments in the presence SN-6, a selective reverse mode NCX inhibitor (25) . Exposure to 30 μM SN-6 did not depress the E max in 12 vessels from 4 control lambs or in 9 vessels from 3 high altitude lambs, nor did it influence the EC 50 of 5-HT (data not shown), indicating no role for the NCX in 5-HT-stimulated contraction in both high altitude and low altitude arteries. In contrast, E max was highly sensitive to the various blockers, and many of these sensitivities were affected by high altitude hypoxia. In general, rho-kinase inhibition was more effective at blocking constriction in vessels from hypoxic lambs compared to normoxic controls. Nifedipine significantly reduced the E max to similar extents in vessels from control and high altitude lambs, and the addition of fasudil reduced contraction further in vessels from both study groups. In both control and high altitude vessels, contraction was abolished by combined blockade of L-type Ca 2+ channels and NSCCs, while reverse-mode NCX blockade had no significant effect in either study group.
In vivo protocol-To further investigate the above evidence of an increased role for rho-kinase in artery contractility in high altitude lambs, we conducted an in vivo study of the effects of fasudil on pulmonary artery pressure in response to acute hypoxia. Twelve lambs were studied, six in the low altitude group (3 males and 3 females) and six in the high altitude group (3 males and 3 females). There was no significant difference between the ages of the low altitude and high altitude lambs at the time of study (15.0 ± 0.7 vs 15.2 ± 0 0.2 days, respectively). Lambs in the low altitude group weighed less than those in the high altitude group (5.7 ± 0.6 vs 7.8 ± 0.7 kg, respectively, p<0.05).
There was no significant difference between the two study groups with respect to baseline arterial pH, pCO 2 , or arterial oxygen content ( Figure 5 ). Hemoglobin concentrations were significantly higher in the high altitude group than in the low altitude group (10.7 ± 0.4 vs 9.1 ± 0.2 g/dl, respectively, p<0.01), resulting in higher baseline arterial oxygen contents (13.8 ± 0.6 vs 12.0 ± 0.3 vol%, respectively, p=0.01).
Both groups received comparable acute hypoxic challenges with arterial oxygen contents falling to 4.7 ± 0.7 and 4.0 ± 0.3 ml/dl during the first hypoxic challenge and 5.2 ± 1.0 and 4.2 ± 0.3 ml/dl during the second hypoxic challenge in the high altitude and low altitude groups, respectively. Arterial pH decreased comparably from baseline during the hypoxic challenge in both low altitude and high altitude groups (p<0.01).
Pulmonary hemodynamics-Following gestation at high altitude, lambs had significantly higher baseline pulmonary artery pressures (21.1 ± 1.9 vs 16.1 ± 1.1 mmHg, respectively, p<0.05) and pulmonary vascular resistances (0.112 ± 0.016 vs 0.078 ± 0.006 mmHg•min•kg•ml -1 respectively, p<0.05) than low altitude controls, as shown in Figure 6 . Other baseline values, including pulmonary capillary wedge pressures (not shown), cardiac output, and heart rate were comparable. In response to 15 min of acute hypoxia, pulmonary artery pressures and vascular resistances increased significantly from baseline in both high altitude and low altitude animals, while cardiac output and heart rate did not change significantly.
Pulmonary capillary wedge pressures did not change significantly with hypoxia and did not vary significantly between the two study groups (data not shown).
Responses to acute hypoxia, expressed as changes from averages of the 15 minutes preceding the start of hypoxia, are shown in Figure 6 . Both pulmonary artery pressure and pulmonary vascular resistance increased significantly more in the high altitude animals than in the low altitude controls during acute hypoxia, whereas cardiac output and heart rate responses were similar in the two groups of animals.
Responses to an intravenous bolus infusion of fasudil are shown after the broken vertical line in
Figures 6 and 7. Fasudil significantly decreased pulmonary artery pressures of both high altitude (from 23 ± 2 to 19 ± 1 mmHg, p<0.05, 1-way ANOVA) and low altitude animals (from 19 ± 2 to 14 ± 1 mmHg, p<0.05). Fasudil administration also reduced cardiac output (from 234 ± 22 to 184 ± 17, p<0.05) in the low altitude animals, with no significant change in high altitude animals. No significant changes were observed in PVR or heart rate following fasudil administration to either group of animals.
Fasudil had no effect on pulmonary artery pressure or vascular resistance responses to acute hypoxia ( Figure 6 ). Following fasudil administration, the low altitude animals demonstrated a greater increase in cardiac output during acute hypoxia, compared to the response observed prior to fasudil administration ( Figure 6 ). In contrast, cardiac output responses to hypoxia were not affected by fasudil administration in the high altitude group. As was observed prior to fasudil administration, heart rate did not change significantly during acute hypoxia in either group after fasudil.
Systemic hemodynamics-There were no significant differences between the high altitude and low altitude groups for baseline mean arterial blood pressure, femoral artery blood flow, and systemic and femoral vascular resistance (Figure 7 ). Acute hypoxia did not result in any significant changes in these three parameters, although systemic blood pressure and femoral vascular resistances tended to decrease in both the high altitude and low altitude animals.
Fasudil administration significantly reduced mean arterial blood pressure in both the low altitude (from 73 ± 4 to 36 ± 5 mmHg, p<0.01, 1-way ANOVA) and high altitude (from 84 ± 7 to 60 ± 6 mmHg, p<0.01) animals. The magnitude of responses to acute hypoxia, expressed as a change from the 15-min period just prior to hypoxia, are shown to the right in Figure 7 . Following fasudil administration, acute hypoxia increased arterial blood pressure (from 36 ± 5 to 48 ± 5 mmHg, p<0.01) and femoral artery flow of low altitude animals relative to the post-fasudil baseline (from 3.0 ml·kg-1·min-1 to 4.7 ± 0.4, p<0.01).
This contrasts with the decrease or lack of pressure and flow responses observed during hypoxia prior to fasudil administration. There was no significant difference in the response of high altitude animals to acute hypoxia before or after fasudil administration. During recovery from the second hypoxic exposure, systemic and femoral vascular resistances of control lambs were significantly lower than those of the high altitude lambs (p<0.01), suggesting the vasodilating effects of fasudil on the peripheral vasculature were less in the high altitude lambs.
Discussion
Experiments in the present study in newborn lambs confirm that antenatal chronic hypoxia due to high altitude living is detrimental to lung vascular function. The sustained moderate antenatal hypoxia of high altitude during the latter portion of gestation, and continuing in the first few days of life, increased basal pulmonary artery pressures and vascular resistance. This prolonged hypoxic exposure enhanced contraction of isolated pulmonary arteries in the presence of KCl or serotonin and in response to acute hypoxia in vivo. The increased contractility of these arteries in the presence of serotonin is not likely due to changes in modes of extracellular Ca 2+ entry, but rather involves an increase in rho-kinase activity. In comparison, rho-kinase activity does not appear to be responsible for the increased response to acute hypoxia in vivo.
Perinatal hypoxia and pulmonary hypertension-The tendency of antenatal (17) and postnatal (6, 16, 24, 62) chronic hypoxia to result in sustained pulmonary hypertension and increased pulmonary contractility has been demonstrated in a number of species. The effects of chronic hypoxia are characterized by an increase in contractile force in response to potassium-mediated depolarization and most pulmonary vasoconstrictors, a decrease in response to endothelium-derived vasodilators, and morphometric changes such as increased medial wall thickness (see review by Shimoda et al (63) . The current study is in agreement with many aspects of these reports, in that isolated pulmonary arteries from the high altitude lambs had increased contractile response to KCl and 5-HT. Further, the high altitude lambs had elevated baseline pulmonary artery pressures and vascular resistances even while breathing 21% O 2 at low altitude.
This observation is consistent with reports from Herrera et al, who observed a similar or increased pressor response to acute hypoxia in newborn lambs exposed to chronic hypoxia in utero on the Andean altiplano (17, 18) . Interestingly, in contrast to the lamb, exposure of adult rats to chronic hypoxia results in an attenuated hypoxic pulmonary vasoconstriction (13, 34). These differences may be due to dissimilarities between rat and sheep, adult and newborn, or whole animal and isolated lung preparations. Together with our current vessel bath studies demonstrating a more prominent role for rho-kinase in 5-HT-stimulated contraction of high altitude compared to low altitude arteries, these findings suggest that suppression of the rho-kinase pathway would be of benefit in treatment of pulmonary hypertension and was one rationale for the present in vivo study. However, our results indicate that although rho-kinase does play a role in the HPV response of newborn lambs, it is not responsible for the heightened HPV response of high altitude lambs. This conclusion is supported by the observation that although fasudil blunted the HPV response in both high altitude and low altitude lambs, the vasopressor response of high altitude lambs remained heightened compared to that of low altitude lambs even following treatment with fasudil. Our finding of a lack of an enhanced role for rho-kinase following chronic hypoxia is contrary to findings of the rodent studies cited above, and may be due to a difference in species or a difference between responses of newborn and adult pulmonary vasculature to hypoxia. It also is possible that increases in rho-kinase activity in the pulmonary arteries of our newborn lambs were masked by a concomitant decrease in rho-kinase activity in pulmonary veins; such a decrease has been reported by Dr.
Rho-kinase and serotonin-mediated contraction-
Raj's group in pulmonary veins of chronically hypoxic fetal sheep (9). However, this possibility is not supported by our observation that pulmonary venous pressures did not differ between the two groups of animals and were unaltered by acute hypoxic insult.
Systemic effects of rho-kinase inhibition-Many pulmonary vasodilators are of limited clinical use because they cause systemic hypotension. Consistent with this concern, we found that intravenous fasudil measurably depressed mean arterial blood pressure systemic and femoral vascular resistance (Figure 7 ).
Fasudil also resulted in a significant decrease in cardiac output with no change in heart rate, suggesting stroke volume was decreased by either a decrease in cardiac contractility or decreased preload. The effect of rho-kinase inhibition on cardiac contractility has not been studied, but in dogs it is reported to increase contractility (64), suggesting that the decrease in cardiac output in our lambs was more likely due to decreased preload caused by the marked fall in peripheral vascular resistance. Notably, these systemic effects were less pronounced in chronically hypoxic lambs, suggesting that the systemic effects of rhokinase inhibition may be attenuated following chronic hypoxia. This observation is in contrast to studies that show adult rats with pulmonary hypertension due to infusion of the prostaglandin analog U-46619 have a greater fall in systemic vascular resistance in response to intravenous fasudil, compared to control rats (2). When considering the potential clinical use of rho-kinase blockers in newborn infants, it is clear that the systemic effects of rho-kinase inhibition warrant further study in various models of pulmonary hypertension before any studies are performed in human infants. It is also possible that administration of rho-kinase inhibitors by an inhaled route may provide pulmonary vasodilation while minimizing systemic effects (37).
Study limitations-The responses of the pulmonary vasculature to prolonged intrauterine hypoxia include greater contractile force and proliferation of vascular smooth muscle. The acute HPV response of isolated rat pulmonary arteries can be divided into a rapid phase of vasoconstriction, lasting about 5 minutes and due largely to increases in intracellular calcium, and a prolonged phase that is dependent on increased calcium sensitivity (54). Rho-kinase appears to play a greater role during the second phase of HPV, as the rho-kinase inhibitor Y-27632 causes only minor attenuation of the first phase of constriction but abolishes the second phase (55). The biphasic HPV response, if present in newborn lambs, is not detectable in vivo by measurement of pulmonary artery pressures (20). While the 15-min acute hypoxic stimulus used in the current study was obviously long enough to assess the first phase of HPV response, it may not have been long enough to fully evaluate the effect of rho-kinase inhibition on the mechanisms that maintain the page 19 of 33 second phase of HPV. A further limitation is that the effects of chronic fasudil administration may differ from those of a single dose. Prolonged administration has been found to prevent or reverse pulmonary hypertension and morphologic changes caused by chronic hypoxia in newborn rats (73) , and thus vary from single dose administration as employed in the present study. Finally, we note that the arteries used for the vessel bath studies were collected from the same lambs used in the in vivo protocol and although both study groups were subjected to the same treatments, we cannot rule out the possibility that the arteries of one group were affected in a different way by the in vivo study protocol.
Summary and Perspective-In summary, we have shown that acclimatization of lambs to moderate hypoxia during gestation and the first few days of life results in an increased contractile response of the pulmonary arteries to both acute hypoxia and 5-HT. Rho-kinase contributes to pulmonary artery tone in both control and high altitude lambs, but does not appear to be involved in the heightened response of high altitude lambs to acute hypoxia. In contrast, rho-kinase does play a role in the increased response of chronically hypoxic pulmonary arteries to 5-HT. These findings imply that multiple mechanisms underly the increased contractility of chronically hypoxic pulmonary arteries. We speculate that hypoxic up regulation of components of contraction that work in parallel with rho-kinase may be involved in increased HPV response. 
